Internal Medicine Resident
Yale New Haven Hospital
New Haven, Connecticut, United States
Dr. Nazli Dizman is an internal medicine resident at Yale School of Medicine, Yale New Haven Hospital. Prior to joining Yale, she graduated from Ege University School of Medicine in Izmir, Turkey and completed her internal medicine residency training at Istanbul Medeniyet University School of Medicine in Istanbul, Turkey. She worked as a postdoctoral fellow in the Department of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center in Duarte, California between 2016 and 2020.
Dr. Dizman has been involved in clinical and translational research projects in the area of genitourinary cancers since 2016. She has played crucial roles in the planning, initiation and management of several clinical and translations studies examining the role of clinical factors, genomics, and the microbiome on clinical outcomes in genitourinary cancers. Dr. Dizman has published over 45 peer-reviewed articles in scientific journals and presented several abstracts at national and international meetings and received a 2022 KCA Trailblazer Award for her research on the “Impact of CBM588 on metabolomic profile in patients with metastatic renal cell carcinoma (mRCC)”. Dr. Dizman will start her Hematology/Oncology training at MD Anderson Cancer Center in Houston, Texas in July 2022.
Disclosure information not submitted.
Modulating gut microbiome to influence outcomes with IO
Saturday, April 22, 2023
14:42 – 14:52 GMT